✦ LIBER ✦
504 POSTER GA101, a therapeutic glycoengineered CD20 antibody recognizing a type II epitope mediates outstanding anti-tumor efficacy in Non-Hodgkin lymphoma xenograft models and superior B cell depletion
✍ Scribed by C. Klein; F. Herting; T. Friess; C. Gerdes; A. Nopora; S. Bauer; R. Grau; E. Moessner; J. Dal Porto; P. Umana
- Book ID
- 119599660
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 59 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.